DPIIT recognised startup Government of India
Startup India
Orris Pharmaceuticals Private Limited
Orris Pharmaceuticals Private Limited - business outsourcing in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹9.35 Cr
▲ 104% YoY
Net profit · FY 2024
₹15.85 Lakh
Net margin 1.7%
EBITDA · FY 2024
₹24.49 Lakh
EBITDA margin 2.6%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Employees · EPFO
46
Provident fund records
Directors on board
2
As per MCA filings
About Orris Pharmaceuticals Private Limited
Data last updated:
Orris Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India, recognised as a startup by DPIIT. It operates in the accounting and financial analysis segment of the business process outsourcing sector. It was incorporated on 01 June 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24110TG2020PTC140528. Its GSTIN is 36AAEFO6268Q1ZG (Telangana). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Gollapudi Srinivasa Rao (Managing Director) and Srinivasa Rao Pappala.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 49.H.No.12 – 13 – 779 1st No 1 Lane No 2 Kimti Colony Siddartha Nagar Tarnaka, Hyderabad, Telangana, India – 500017.
As per the financials filed for FY 2024, the company reported a revenue of ₹9.35 Cr, a growth of 104% compared to the previous year. For the same year it recorded a net profit of ₹15.85 Lakh (net margin 1.7%) and EBITDA of ₹24.49 Lakh (EBITDA margin 2.6%).
The company has about 46 employees on its provident fund (EPFO) records.
Orris Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0051737).
Company details
CIN U24110TG2020PTC140528
Registration Number 140528
Incorporation Date 01 June 2020
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-TS-20-0051737
Recognitions & Rankings of Orris Pharmaceuticals
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-20-0051737
Contact details
Orris Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No 49.H.No.12 – 13 – 779 1st No 1 Lane No 2 Kimti Colony Siddartha Nagar Tarnaka, Hyderabad, Telangana, India – 500017
- IndustryBusiness Outsourcing, Accounting and Financial Analysis
To see the full contact details of Orris Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Orris Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Orris Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Orris Pharmaceuticals Private Limited, buy the company report.
Financials of Orris Pharmaceuticals Private Limited
FY 2025 filings availableOrris Pharmaceuticals Private Limited reported revenue of ₹9.35 Cr (up 104% YoY) for FY 2024.
Revenue · FY 2024
₹9.35 Cr ▲ 104%
Net profit · FY 2024
₹15.85 Lakh margin 1.7%
EBITDA · FY 2024
₹24.49 Lakh margin 2.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 104%
EBITDA CAGR growth
1 year
▲ 130%
Revenue rose 104% in the latest year. EBITDA rose 130% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹24.49 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹15.85 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 2.6% | |||
| Net Profit Margin | 1.7% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Orris Pharmaceuticals Private Limited, buy the company report.
Board of directors of Orris Pharmaceuticals Private Limited
Orris Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srinivasa Rao Pappala Also directs: Orris Educational & Medical Foundation | Director | 01 Jun 2020 | 6 Years 5 Months | Current |
| Gollapudi Srinivasa Rao Also directs: Vrise Health Solutions LLP, Orris Educational & Medical Foundation | Managing Director | 01 Jun 2020 | 6 Years 5 Months | Current |
Auditor
Orris Pharmaceuticals Private Limited is audited by NAVEEN MADIVADA & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NAVEEN MADIVADA & CO | FY 2023 | 016816S |
Shareholding
The shareholding of Orris Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Orris Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Orris Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Orris Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Orris Pharmaceuticals Private Limited has a workforce of 46 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
Employee count
46
Active EPFO establishments
1
Employee growth
9.52%
GST
Orris Pharmaceuticals has 3 GST registrations: 3 active.
Total GSTINs
3
Active
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAEFO6268Q1ZG | Telangana | Active | 01 Jul 2017 |
| 36AADCO1642C1ZW | Telangana | Active | 01 Apr 2021 |
| 37AAEFO6268Q1ZE | Andhra Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Orris Pharmaceuticals Private Limited, buy the company report.
Recent activity
Orris Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Gollapudi Srinivasa Rao was appointed as Managing Director on 01 Jun 2020.
AGM
Orris Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Orris Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Appointed
Gollapudi Srinivasa Rao was appointed as Managing Director.
Appointed
Srinivasa Rao Pappala was appointed as Director.
Incorporation
01 Jun 2020
Orris Pharmaceuticals Private Limited was registered on 01 Jun 2020 with Roc Hyderabad & aged 6 years 5 months as per MCA records.
Frequently asked questions
Orris Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in accounting and financial analysis, within the business outsourcing industry. It was incorporated on 01 June 2020 (6+ years old) and is registered under CIN U24110TG2020PTC140528.
Orris Pharmaceuticals has 2 current directors:
- Gollapudi Srinivasa Rao - Managing Director
- Srinivasa Rao Pappala - Director
The latest financial statements of Orris Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Orris Pharmaceuticals is 36AAEFO6268Q1ZG, registered in Telangana. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 36AADCO1642C1ZW (Telangana), 37AAEFO6268Q1ZE (Andhra Pradesh).
The CIN (Corporate Identification Number) of Orris Pharmaceuticals is U24110TG2020PTC140528. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Orris Pharmaceuticals was incorporated on 01 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
Gollapudi Srinivasa Rao was appointed as Managing Director on 01 Jun 2020. Srinivasa Rao Pappala was appointed as Director on 01 Jun 2020.
Yes, Orris Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Orris Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-20-0051737).
The registered office of Orris Pharmaceuticals is at Plot No 49.H.No.12 – 13 – 779 1st No 1 Lane No 2 Kimti Colony Siddartha Nagar Tarnaka, Hyderabad, Telangana, India – 500017.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages